Th1 and Th2 Immune Response in Chronic Hepatitis B Patients during a Long-Term Treatment with Adefovir Dipivoxil

Adefovir dipivoxil treatment has significantly improved the outcome of chronic hepatitis B virus (HBV) infection. However, it remains largely unknown how immune system responds to the treatment. Chronic HBV patients were treated with adefovir dipivoxil and examined for serum HBV DNA loads, cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yanfang, Ma, Zhenhua, Xin, Guijie, Yan, Hongqing, Li, Wanyu, Xu, Huining, Hao, Chunhai, Niu, Junqi, Zhao, Pingwei
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994066/
https://www.ncbi.nlm.nih.gov/pubmed/21127728
http://dx.doi.org/10.1155/2010/143026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994066/
https://www.ncbi.nlm.nih.gov/pubmed/21127728
http://dx.doi.org/10.1155/2010/143026

Ejemplares similares